Suraxavir marboxil
Suraxavir marboxil (GP681; Cap-dependent endonuclease-IN-3) is a PA subunit cap-dependent endonuclease inhibitor with antiviral activity. Suraxavir marboxil inhibits PA subunit cap-dependent endonuclease activity and inhibits influenza A and/or influenza B viral replication. Suraxavir marboxil can be used alone or in combination with other anti-influenzal agents for the prevention of influenza A and/or influenza B viral infectious diseases. Suraxavir marboxil can be used for the research of influenza A and/or influenza B viral infectious diseases.
商品は「研究用試薬」です。人や動物の医療用・臨床診断用・食品用の製品ではありません。
研究用途以外に使用した場合、当社は一切の責任を負いかねます。
- CAS 番号: 2364589-86-4
- 分子式: C29H25F2N3O7S
- 分子量:597.59
-
保管条件:
Please store the product under the recommended conditions in the Certificate of Analysis.
生物活性
製品説明
Parmacokinetics
| Species | Dose | Route | T1/2 | Tmax | Cmax | AUC0-t | F |
|---|---|---|---|---|---|---|---|
| Rat[1] | 3.0 mg/kg | i.g. | 3.32 h | 1.67 h | 253 ng/mL | 1377 ng·h/mL | 47.2 % |
体内実験
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:BALB/c mice infected with A/WS/33 (H1N1) virus[1]
-
Dosage:15 mg/kg
-
Administration:P.o.; daily for 5 days
-
Result:Achieved a statistically significant reduction in lung influenza virus titers.
Increased survival rate to 100%.
臨床実験
| NCT Number | Sponsor | Condition | Start Date |
Phase
|
|---|---|---|---|---|
| NCT01329991 | Plexxikon| | 2011-05 | PHASE1 |
化学情報
-
CAS 番号 2364589-86-4
-
分子量 597.59
-
分子式 C29H25F2N3O7S
-
SMILES
O=C1N2[C@](COC3(CC3)C2)([H])N([C@@]4([H])C5=CC=C(F)C(F)=C5CSC6=CC=CC=C64)N7C1=C(C(C=C7)=O)OCOC(OC)=O
-
別名
GP681; Cap-dependent endonuclease-IN-3
-
輸送条件
Room temperature in continental US; may vary elsewhere.
-
保管条件
Please store the product under the recommended conditions in the Certificate of Analysis.
純度とドキュメンテーション
参考文献
Calculators
濃度 (開始) × 体積 (開始) = 濃度 (終了) × 体積 (終了)